ANI Pharmaceuticals Canada, Inc.
⚠️ Moderate Risk
FEI: 3002916530 • Oakville, Ontario • CANADA
FEI Number
3002916530
Location
Oakville, Ontario
Country
CANADAAddress
400 Iroquois Shore Rd, , Oakville, Ontario, Canada
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 7/20/2017 | 56ECA60MINOCYCLINE (TETRACYCLINES) | Division of Northern Border Imports (DNBI) | |
| 7/20/2017 | 56ECA60MINOCYCLINE (TETRACYCLINES) | Division of Northern Border Imports (DNBI) | |
| 7/20/2017 | 56ECA60MINOCYCLINE (TETRACYCLINES) | Division of Northern Border Imports (DNBI) | |
| 7/27/2016 | 61NCB60TRAZODONE HCL (ANTI-DEPRESSANT) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 7/27/2016 | 61NCB60TRAZODONE HCL (ANTI-DEPRESSANT) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 8/26/2008 | 56ECA61MINOCYCLINE HYDROCHLORIDE (TETRACYCLINES) | 75UNAPPROVED | New York District Office (NYK-DO) |
| 12/13/2001 | 66VBH99MISCELLANEOUS PATENT MEDICINES, ETC. | New York District Office (NYK-DO) |
Frequently Asked Questions
What is ANI Pharmaceuticals Canada, Inc.'s FDA import refusal history?
ANI Pharmaceuticals Canada, Inc. (FEI: 3002916530) has 7 FDA import refusal record(s) in our database, spanning from 12/13/2001 to 7/20/2017.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. ANI Pharmaceuticals Canada, Inc.'s FEI number is 3002916530.
What types of violations has ANI Pharmaceuticals Canada, Inc. received?
ANI Pharmaceuticals Canada, Inc. has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about ANI Pharmaceuticals Canada, Inc. come from?
All FDA import refusal data for ANI Pharmaceuticals Canada, Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.